# cdm-automation — DEVICEV validation report

Target page: https://mickael-umt.com/expertises/cdm-automation/
Repository artifact: `expertises/cdm-automation/cdm-automation.html`
Baseline blob SHA: `735b704e6e30d08dc9292f261aa7b4a5414553b8`
Validation date: 2026-09-03
Policy source: `@neofort`
Execution posture: `FAIL_CLOSED`

## Result

`FINAL_PASS = false`

The requested evidence-bearing HTML rewrite was **not committed** because the current evidence graph does not satisfy the requested publication threshold and the current @neofort hard gates.

Current page-targeted proof-carrying inventory:

- `EU-CANON-EMA-CLINICAL-DATA-ROUTINE-2028` — current; deterministic preflight PASS; Factfulness PASS; agent exploitability ALLOWED.
- `EU-CANON-EMA-NDSG-WORKPLAN-2026-2028` — current; deterministic preflight PASS; Factfulness PASS; agent exploitability ALLOWED.
- Current admitted/published `QuestionDrivenGraphEvidenceUnit` objects for this page: **0**.

Requested minimum for this execution:

- more than 8 distributed EvidenceUnit placements;
- more than 3 graph EvidenceUnit placements;
- graph placements must pass current EUG data-visualization, provenance, Factfulness, agent-exploitability, presentation and exact-XPath gates.

Therefore the deterministic publication condition is not met.

## Structure baseline retained

The existing dark-mode reconstruction already preserves a 17-section structure and the required progressive-disclosure citation component `.lp-evidence-bubble-scroll`.

Section order is retained as the immutable structural baseline:

1. `triggers`
2. `consequences`
3. `audience`
4. `qualification`
5. `proposition`
6. `offers`
7. `deliverables`
8. `before-after`
9. `results`
10. `proofs`
11. `scope`
12. `process`
13. `modules`
14. `intersection`
15. `commitments`
16. `questions`
17. `engagement`

No section was added, deleted or reordered.

## Current @neofort policy snapshot used

- `evidence-placement-policy:site-v5`
- `judge:evidence:factfulness-epistemology-methodology-v2`
- `judge:evidence-unit:champion-v2`
- `judge:evidence-graphic:presentation-v1`
- `judge:evidence-placement:presentation-v1.2`
- `policy:evidence-agent-exploitability:deterministic-preflight-v2`
- `policy:evidence-agent-exploitability:proof-carrying-v3`
- `policy:evidence-judge-applicability:v2`
- `policy:evidence-judge-verdict-normalization:v2`
- `policy:evidence-placement:claim-span-entailment-v2`
- `policy:evidence-unit-judge:source-dominance-v2`
- `policy:evidence:canonical-epistemic-classification-v2`
- `policy:evidence:factfulness-replacement-v2`
- `policy:llm-judge:deterministic-execution-v2`
- `policy:qgeu:data-visualization-analyst-v1`

The current policy requires exact claim-span entailment, one selected EU per placement, exact selector/XPath resolution, accessible Level-2 disclosure, 3 deterministic LLM judge replicas, AND reduction for hard gates, MIN reduction for scores and blocking on disagreement.

## Research candidates reviewed in this pass

### Retained as high-priority primary-source candidates

1. FDA — *Study Data Technical Conformance Guide*, June 2026.
   https://www.fda.gov/media/153632/download

2. FDA — *Study Data Standards Resources* and current validation/business-rule resources.
   https://www.fda.gov/industry/fda-data-standards-advisory-board/study-data-standards-resources

3. FDA — *Study Data for Submission to CDER and CBER*.
   https://www.fda.gov/industry/study-data-standards-resources/study-data-submission-cder-and-cber

4. FDA CDER — Data Standards Program current public material and 2025 Annual Assessment published in 2026.

5. FDA — eCTD v4 submission standards/current validator configuration, with multiple 2026 updates.

6. EMA/HMA — Network Data Steering Group workplan 2026–2028.
   https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/network-data-steering-group-ndsg

7. EMA — clinical-study-data pilot/follow-up public material.

8. Independent academic candidate — *LLM-Assisted Clinical Data Harmonization: Combining Automated ETL Generation with Semantic Vocabulary Mapping for OMOP CDM* (2026). Requires full open-method materialisation and complete admission before page use.

9. Independent academic candidate — recent FHIR versus OMOP evaluation using All of Us data. Requires full open-method materialisation, source snapshot and admission before page use.

### Rejected from public evidence placement

- PRomop / arXiv 2607.13947: quantitatively rich but evaluates/promotes a named commercial/vendor-associated solution. Under the active competitive-product gate it cannot be used as a generic independent proof source for this consulting offer.

- Gartner / commercial forecast material previously associated with CDM: not admissible as primary technical evidence for this page under the current source-dominance rules.

- Retired legacy CDM EvidenceUnits in @neofort: cannot be repaired in place; their current status is RETIRED / Factfulness FAIL and replacement must be immutable.

## Required next gate sequence before HTML mutation

`SOURCE → deterministic preflight → proof-carrying Factfulness → applicable EU judge → agent exploitability → CopySequence claim-span placement → exact XPath/selector validation → EUG graph-quality/presentation gate where applicable → final presentation gate → GitHub HTML update`

The HTML file must remain unchanged until at least nine distributed EU placements and four admitted graph placements satisfy the full current policy chain.

## Repository action

The baseline `cdm-automation.html` was fetched before any contemplated mutation and its SHA was preserved. Because `FINAL_PASS=false`, no HTML update was performed. This report records the blocked state without altering the public reconstruction.

Google Drive was not accessed or modified.
